Taper Quetiapine Gradually Over 1-2 Weeks
After only one week of quetiapine 75 mg three times daily (225 mg/day total), you should taper the medication rather than stop abruptly, though the taper can be relatively brief given the short duration of use.
Rationale for Tapering
While quetiapine has a short plasma half-life of approximately 2.5-5 hours 1, withdrawal symptoms can occur even after brief exposure. The drug demonstrates receptor occupancy that persists longer than plasma levels suggest—dopamine D2 receptor occupancy has a half-life of approximately 10 hours, and serotonin 5-HT2 receptor blockade can persist for 27 hours 1. This pharmacodynamic profile means abrupt cessation can precipitate withdrawal symptoms including nausea, vomiting, insomnia, and rebound agitation 2.
Recommended Tapering Schedule
Given the one-week duration of use at 225 mg/day, implement a rapid but gradual taper over 1-2 weeks:
- Days 1-3: Reduce to 150 mg/day (50 mg three times daily)
- Days 4-6: Reduce to 75 mg/day (25 mg three times daily)
- Days 7-9: Reduce to 25-50 mg/day (single evening dose)
- Day 10: Discontinue
This approach follows the principle that gradual tapering minimizes withdrawal symptoms 3, 4, while recognizing that shorter exposure periods require less prolonged tapers compared to long-term use.
Key Clinical Considerations
Monitor for withdrawal symptoms during the taper, including:
- Nausea and vomiting (most commonly reported) 2
- Insomnia and anxiety
- Rebound agitation
- Dizziness
Adjust the taper pace if withdrawal symptoms emerge—you can slow the reduction or pause at any dose level 5. The taper rate should be determined by the patient's ability to tolerate it 5.
Do not stop abruptly unless there is a severe adverse event requiring immediate cessation 5. Even after one week of use, abrupt discontinuation risks unnecessary patient distress from withdrawal symptoms.
Special Populations
For older or frail patients, use even more conservative dose reductions (e.g., extend the taper to 2-3 weeks) as they are at higher risk for adverse effects including falls, orthostatic hypotension, and cognitive changes 6, 7.